Strong future growth

  1. 4,668 Posts.
    lightbulb Created with Sketch. 1321
    Greencross reported sales were up 14.5 per cent in the first 43 weeks of the 2015/2016 financial year and revealed plans to add more stores (21) and more in-store co-located vet clinics (14) to its network before July. Greencross vets are getting cross referrals from their retail network.
    Now Greencross can fend off a hostile takeover. That's why Quadrant has sold down and the view is that the takeover premium is removed.

    Greencross strength is driven by a strong veterinary sector in Australia and NZ, strong future growth and scale. Those factors and the undervalued share price make GXL very attractive buy.

    :}
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.